All In Biotech

Drug Trial Radar · NCT06628128

A Long-Term Study of JNT-517 in Participants With Phenylketonuria

An Open-Label Study to Evaluate the Long-Term Safety of JNT-517 in Participants With Phenylketonuria

Last checked: Nov 19, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Aug 11, 2025

Primary completion

Nov 1, 2027

Study completion Feb 1, 2028

Sponsor

Sponsor type
Industry
First posted
Oct 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this Phase 3, open-label study is to evaluate the long-term safety of JNT-517 in pediatric and adult participants with Phenylketonuria (PKU) after completion of either Study JNT517-101 (NCT05781399) or JNT517-201 (NCT06637514) as well as participants who have not participated in a prior JNT-517 study. In this trial, all participants will receive JNT-517 using age- and weight-banded dosing as outlined in the protocol, regardless of any dose received in a previous study.

Conditions

  • Phenylketonuria (PKU)

Interventions

  • JNT-517Drug

    JNT-517 administered orally twice daily using age- and weight-banded dosing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with Treatment-emergent Adverse Events (TEAEs)Time frame: Screening to +2 weeks from last dose

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Florida (UF) Health Shands Hospital

    Gainesville, Florida · Recruiting

  • University of South Florida

    Tampa, Florida · Recruiting

  • Oregon Health and Science University

    Portland, Oregon · Recruiting

  • University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania · Recruiting

  • Children's Medical Center Dallas

    Dallas, Texas · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • University of Texas Health (UTHealth) Science Center at Houston

    Houston, Texas · Recruiting

  • Utah Health - The University of Utah Hospital

    Salt Lake City, Utah · Recruiting

  • Children's Health Queensland - Queensland Children's Hospital

    South Brisbane, Queensland, Australia · Recruiting

  • Mater Health - Mater Hospital Brisbane

    South Brisbane, Queensland, Australia · Recruiting

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia · Recruiting

  • Murdoch Children's Research Institute

    Parkville, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.